Gyre Therapeutics Inc

Research Gyre Therapeutics Inc (GYRE) on Bullrun: market cap USD 625.83M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerGYRE
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 625.83M
• Financial periodFY2025
• RevenueUSD 116.59M
• Revenue growth10.2%
• Net incomeUSD 9.88M
• Free cash flow-USD 180.00K
• Gross margin95.4%

Valuation Snapshot

latest market cap is USD 625.83M.

About Gyre Therapeutics Inc

Gyre Therapeutics, Inc., a pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis. The company offers ETUARY (Pirfenidone), an anti-fibrotic drug approved for the treatment of idiopathic pulmonary fibrosis; and under Phase 3 trials for the treatment of pneumoconiosis.

Frequently asked questions

What is Gyre Therapeutics Inc's market cap?

Gyre Therapeutics Inc's market capitalization is USD 625.83M.

What does Gyre Therapeutics Inc do?

Gyre Therapeutics, Inc., a pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis.